Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Gynaecological-Cancers-Congress-2023-1000x250

Abstract submission is now open

Submit your Abstract

Abstract submission deadlines

Deadline

Date and time

  • Abstract 
  • Trial in Progress

Tuesday, 29 November 2022, 21:00hrs CET
(Central European Time)

Outcome notifications

Outcome notifications are expected to be made available to first authors and submitters by 16 December 2022.

Submission categories

  • Basic and translational research
  • Cervical cancer
  • Endometrial cancer
  • Ovarian cancer
  • General interest

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Gynaecological Cancers Congress 2023.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design

Notes:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of Tuesday, 29 November 2022.
  • Abstracts including results or preliminary data will be rejected.
  • Trial in Progress abstracts will be accepted for Poster outcome only.
  • Encore TiP abstracts will not be accepted.

Publication schedule of accepted abstracts

Details regarding the publication of accepted abstracts will be available on this page in due time.

Details regarding ESMO press activities will be made available 10 days prior to the Congress.

Embargo policy

Data and information included in accepted abstracts is under embargo until the relevant embargo release date cited in the schedule above.

Data and information beyond what is included in all accepted abstracts, for example full data sets, may only be made public at the start of the official programme session during which the study is presented.

Presentation of accepted abstracts

The ESMO Gynaecological Cancers Congress 2023 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

  • Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
  • Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts will be published online in the ESMO Gynae 2023 Abstract Book, a supplement to ESMO Open.

ESMO Merit Travel Grants

A restricted number of ESMO Merit Travel Grants to the ESMO Gynaecological Cancers Congress 2023 are available, upon application, to first author (= presenter) who submit abstracts considered to be deserving of recognition.

Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO Gynaecological Cancers 2023 Scientific Committee on a competitive basis from among the accepted abstracts.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.